File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

TitleTenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Authors
Buti, MGane, ESeto, WKWChan, HLChuang, WLStepanova, THui, AJLim, YSMehta, RJanssen, HAcharya, SKFlaherty, JMassetto, BCathcart, ALKim, KGaggar, ASubramanian, GMMcHutchison, JPan, CBrunetto, MIzumi, NMarcellin, P
Issue Date2016
Citation
The Lancet Gastroenterology & Hepatology, 2016, v. 1, p. 196-206 How to Cite?
DOI: http://dx.doi.org/10.1016/S2468-1253(16)30107-8
Persistent Identifierhttp://hdl.handle.net/10722/237764
ISI Accession Number ID
WOS:000438434000019

 

DC FieldValueLanguage
dc.contributor.authorButi, M-
dc.contributor.authorGane, E-
dc.contributor.authorSeto, WKW-
dc.contributor.authorChan, HL-
dc.contributor.authorChuang, WL-
dc.contributor.authorStepanova, T-
dc.contributor.authorHui, AJ-
dc.contributor.authorLim, YS-
dc.contributor.authorMehta, R-
dc.contributor.authorJanssen, H-
dc.contributor.authorAcharya, SK-
dc.contributor.authorFlaherty, J-
dc.contributor.authorMassetto, B-
dc.contributor.authorCathcart, AL-
dc.contributor.authorKim, K-
dc.contributor.authorGaggar, A-
dc.contributor.authorSubramanian, GM-
dc.contributor.authorMcHutchison, J-
dc.contributor.authorPan, C-
dc.contributor.authorBrunetto, M-
dc.contributor.authorIzumi, N-
dc.contributor.authorMarcellin, P-
dc.date.accessioned2017-01-20T02:28:13Z-
dc.date.available2017-01-20T02:28:13Z-
dc.date.issued2016-
dc.identifier.citationThe Lancet Gastroenterology & Hepatology, 2016, v. 1, p. 196-206-
dc.identifier.urihttp://hdl.handle.net/10722/237764-
dc.languageeng-
dc.relation.ispartofThe Lancet Gastroenterology & Hepatology-
dc.titleTenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial-
dc.typeArticle-
dc.identifier.emailSeto, WKW: wkseto2@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.doi10.1016/S2468-1253(16)30107-8-
dc.identifier.scopuseid_2-s2.0-84996538096-
dc.identifier.hkuros270979-
dc.identifier.volume1-
dc.identifier.spage196-
dc.identifier.epage206-
dc.identifier.isiWOS:000438434000019-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats